A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Renal Impairment
Taiho Oncology, Inc.
Taiho Oncology, Inc.
Pfizer
Celldex Therapeutics
Celldex Therapeutics
Celldex Therapeutics
Amgen
Merck Sharp & Dohme LLC
Astellas Pharma Inc
Apeiron Biologics